ReviewCancers2022

Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer Part 2: Medical Perspectives.

Stanislas Quesada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.